FDA Import Refusal 660-2544606-4/21/2 — RAJSHA PHARMACEUTICALS
The FDA refused shipment 660-2544606-4/21/2 from RAJSHA PHARMACEUTICALS (India) on Dec 8, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 8, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75